Earnings Call · Q1 FY2023·2023-05-03

Q1 23EPS +69.35%·Rev n/aQ4 22EPS +32.56%·Rev n/aQ3 22EPS +1.15%·Rev n/aQ2 22EPS +3.70%·Rev n/a⚠ consensus missing

FATE THERAPEUTICS INC FATE

Scott Wolchko — Chief Executive Officer (CEO)

Ed Dulac — Chief Financial Officer (CFO)

−2.4%1d on move date−1.7% vs SPY3d−13.8%5d−15.5%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FATE calls or request research access.

More FATE calls Browse calls Request research access